Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Waldenstrom Macroglobulinemia × aldesleukin × 30 days × Clear all

Sponsor

Conditions

Ovarian Neoplasms 3 Leukemia, Myeloid, Acute 3 Vulvar Neoplasms 2 Urogenital Neoplasms 2 Pancreatic Neoplasms 2 Melanoma 2 Carcinoma, Non-Small-Cell Lung 2 Breast Neoplasms 2 Vulvar Diseases 1 Vaginal Neoplasms 1 Uterine Cervical Neoplasms 1 Uterine Cervical Dysplasia 1 Stomach Neoplasms 1 Recurrence 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pleural Effusion, Malignant 1 Penile Neoplasms 1 Papillomavirus Infections 1 Oropharyngeal Neoplasms 1 Neuroendocrine Tumors 1 Neuroblastoma 1 Neoplasm Metastasis 1 Myelodysplastic Syndromes 1 Multiple Myeloma 1 Mesothelioma, Malignant 1 Meningeal Neoplasms 1 Leukemia, Myeloid 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Leukemia 1

Interventions

ibrutinib 4 Rituximab 4 zanubrutinib 3 venetoclax 2 ixazomib 2 Specimen Handling 2 Prednisone 2 Magnetic Resonance Spectroscopy 2 Cyclophosphamide 2 CT-P10 2 Biopsy 2 talquetamab 1 pirtobrutinib 1 fludarabine 1 brexucabtagene autoleucel 1 Vincristine 1 Valacyclovir 1 Sirolimus 1 Pharmacogenomic Variants 1 Lenalidomide 1 Everolimus 1 Etoposide 1 Doxorubicin 1 Bortezomib 1 ARQ531 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡